These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2790000)
1. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors. Hanson JE; Kaplan AP; Bartlett PA Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range. Kaplan AP; Bartlett PA Biochemistry; 1991 Aug; 30(33):8165-70. PubMed ID: 1868091 [TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes. Kim H; Lipscomb WN Biochemistry; 1990 Jun; 29(23):5546-55. PubMed ID: 2386784 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the structures of three carboxypeptidase A-phosphonate complexes determined by X-ray crystallography. Kim H; Lipscomb WN Biochemistry; 1991 Aug; 30(33):8171-80. PubMed ID: 1868092 [TBL] [Abstract][Full Text] [Related]
5. Slow- and fast-binding inhibitors of thermolysin display different modes of binding: crystallographic analysis of extended phosphonamidate transition-state analogues. Holden HM; Tronrud DE; Monzingo AF; Weaver LH; Matthews BW Biochemistry; 1987 Dec; 26(26):8542-53. PubMed ID: 3442675 [TBL] [Abstract][Full Text] [Related]
7. Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters. Bone R; Sampson NS; Bartlett PA; Agard DA Biochemistry; 1991 Feb; 30(8):2263-72. PubMed ID: 1998685 [TBL] [Abstract][Full Text] [Related]
8. Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin. Bartlett PA; Marlowe CK Biochemistry; 1987 Dec; 26(26):8553-61. PubMed ID: 3442676 [TBL] [Abstract][Full Text] [Related]
9. Effect of polar head groups on the interactions of phospholipase A2 with phosphonate transition-state analogues. Yu L; Dennis EA Biochemistry; 1993 Sep; 32(38):10185-92. PubMed ID: 8399145 [TBL] [Abstract][Full Text] [Related]
10. Transition-state characterization: a new approach combining inhibitor analogues and variation in enzyme structure. Phillips MA; Kaplan AP; Rutter WJ; Bartlett PA Biochemistry; 1992 Feb; 31(4):959-63. PubMed ID: 1734971 [TBL] [Abstract][Full Text] [Related]
11. Stereoselective inhibition of glutamate carboxypeptidase by chiral phosphonothioic acids. Lu H; Berkman CE Bioorg Med Chem; 2001 Feb; 9(2):395-402. PubMed ID: 11249132 [TBL] [Abstract][Full Text] [Related]
12. Phosphonamidates as transition-state analogue inhibitors of thermolysin. Bartlett PA; Marlowe CK Biochemistry; 1983 Sep; 22(20):4618-24. PubMed ID: 6626519 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor. Bartlett PA; Marlowe CK Science; 1987 Jan; 235(4788):569-71. PubMed ID: 3810155 [TBL] [Abstract][Full Text] [Related]
18. Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway. Lee KJ; Kim DH Bioorg Med Chem; 1998 Sep; 6(9):1613-22. PubMed ID: 9801832 [TBL] [Abstract][Full Text] [Related]
19. Kinetics and mechanism of beta-lactamase inhibition by phosphonamidates: the quest for a proton. Rahil J; Pratt RF Biochemistry; 1993 Oct; 32(40):10763-72. PubMed ID: 8399224 [TBL] [Abstract][Full Text] [Related]
20. Peptidic phosphonylating agents as irreversible inhibitors of serine proteases and models of the tetrahedral intermediates. Sampson NS; Bartlett PA Biochemistry; 1991 Feb; 30(8):2255-63. PubMed ID: 1998684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]